JADI

0.055

-0.005 (-8.3%)

OTHERS JADI IMAGING HOLDINGS BERHAD (JIH OR THE COMPANY) CONDITIONAL APPROVAL GRANTED BY THE MEDICAL DEVICE AUTHORITY (MDA) OF MALAYSIA TO JADI LIFE SOLUTIONS SDN BHD (JLS), A WHOLLY-OWNED SUBSIDIARY OF JIH FOR THE DISTRIBUTION OF COVID-19 ANTIGEN SELF-TEST KITS (SALIVA)

JADI IMAGING HOLDINGS BERHAD

Type Announcement
Subject OTHERS
Description
JADI IMAGING HOLDINGS BERHAD (JIH OR THE COMPANY)  CONDITIONAL APPROVAL GRANTED BY THE MEDICAL DEVICE AUTHORITY (MDA) OF MALAYSIA TO JADI LIFE SOLUTIONS SDN BHD (JLS), A WHOLLY-OWNED SUBSIDIARY OF JIH FOR THE DISTRIBUTION OF COVID-19 ANTIGEN SELF-TEST KITS (SALIVA)

The Board of Directors of Jadi Imaging Holdings Berhad (“JIH” or “the Company”) (“the Board”) wishes to announce that the Company’s wholly-owned subsidiary, Jadi Life Solutions Sdn Bhd (“JLS”) had on 25 April 2022 received conditional approval from the Medical Device Authority (“MDA”) under the Ministry of Health Malaysia for the distribution of COVID-19 Antigen Self-Test Kits (Saliva) manufactured by Dyna Source Sdn Bhd (“Dyna Source”), namely Biodetect Rapid Sars Cov 2 Antigen Test Kit in Malaysia.
Dyna Source was established by a group of experienced teams in the medical market and industry, dedicating themselves in the belief that transformation is followed with good applications. With continuous development and advancement of the daily human life, Dyna Source aims to respond to changes in the world to deliver better solutions for the society’s wellbeing. Dyna Source is a registered company with MDA and Good Distribution Practice for Medical Devices (“GDPMD”) of the Malaysian authority. 
JLS is the digital-centric brand that helps consumers be smarter in finding best value in quality products at affordable prices. Building on this mindset, we are creating a culture to be curious and to know the value of quality products that are not only perceived by the brands or labels that are tagged on them – with better accessibility to the said products. From office to school supplies, JLS also has an active role in the creative supplies and health care segments. 
Biodetect Rapid Sars Cov 2 Antigen Test Kit allows faster and more accurate screening of individuals. It is more user-friendly as it uses saliva specimen as opposed to the rapid antigen tests which use nasopharyngeal swabs to collect “nasal” specimen which may cause discomfort.
Barring any unforeseen circumstances, the conditional approval from MDA for the distribution of COVID-19 Antigen Self-Test Kits (Saliva) will not have material impact on the financial position of JIH for the financial year ending 31 March 2023.
The Board of JIH is of the opinion that the distribution and supply of the said COVID-19 Antigen Self-Test Kits (Saliva) is in the best interest of the Company after considering its business potential in the prevailing COVID-19 self-test public awareness and support by the Government as an important initiative to combat the spread of COVID-19 infections. 
This announcement is dated 25 April 2022






Announcement Info

Company Name JADI IMAGING HOLDINGS BERHAD
Stock Name JADI
Date Announced 25 Apr 2022
Category General Announcement for PLC
Reference Number GA1-15022022-00047